Document is current
Any future updates will be listed below
-
Authors
El Hamaoui, Divina https://orcid.org/0000-0003-1384-1207
Marchelli, Aurore
Gandrille, Sophie
Reboul, Etienne https://orcid.org/0000-0003-0759-4756
Stepanian, Alain
Palmier, Bruno
Jovine, Luca https://orcid.org/0000-0002-2679-6946
Lebrin, Franck https://orcid.org/0000-0002-1650-6757
Smadja, David M.
Bernabeu, Carmelo https://orcid.org/0000-0002-1563-6162
Denis, Cecile V. https://orcid.org/0000-0001-5152-9156
Gaussem, Pascale https://orcid.org/0000-0002-9139-2147
Pasquali, Samuela
Kauskot, Alexandre https://orcid.org/0000-0002-4064-8114
Rossi, Elisa https://orcid.org/0000-0002-0570-6104
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 15 February 2025
First Online: 26 February 2025
Competing interests
: A patent (No. EP24307100) entitled ‘Peptide derived from endoglin for treating bleeding disorders’ was filed by inventor Elisa Rossi and supported by INSERM Transfert (Institut National de la Santé et de la Recherche Médicale) in France.
